Sökning: "Anders Bergh"
Visar resultat 16 - 20 av 24 avhandlingar innehållade orden Anders Bergh.
16. Tumor instructed normal tissue : studies of potential extratumoral biomarkers and therapeutic targets in prostate cancer
Sammanfattning : Prostate cancer is the most common cancer in men in Sweden and but luckily the majority of the patients will carry on their life without any consequences from the disease. Unfortunately, some will develop aggressive tumors and eventually die. LÄS MER
17. Vascular density and bone marrow fibrosis in childhood acute lymphoblastic leukemia
Sammanfattning : Background: In childhood acute lymphoblastic leukemia (ALL), the cure rate has now reached 80% in the western world. Even so, 15¬–20% will die from the disease or treatment-related causes, among them children who did not present any known unfavorable features at diagnosis. LÄS MER
18. Early effects of castration therapy in non-malignant and malignant prostate tissue
Sammanfattning : Early Effects of Castration Therapy in Non-malignant and Malignant Prostate Tissue BACKGROUND. Androgen ablation, the standard treatment for advanced prostate cancer, results in increased apoptosis, decreased cell proliferation and subsequent involution of the prostate gland. LÄS MER
19. Predicting surfacing internal erosion in moraine core dams
Sammanfattning : Dams that comprise broadly and widely graded glacial materials, such as moraines, have been found to be susceptible to internal erosion, perhaps more than dams of other soil types. Internal erosion washes out fine-grained particles from the filling material; the erosion occurs within the material itself or at an interface to another dam zone, depending on the mode of initiation. LÄS MER
20. Angiogenesis in human renal cell carcinoma : hypoxia, vascularity and prognosis
Sammanfattning : Background: Angiogenesis is recognised as a critical step in tumour progression. The angiogenic switch is activated by various trigger signals, such as hypoxia, low pH, and genetic mutations. Renal cell carcinoma (RCC) is often an aggressive tumour, and advanced disease has limited treatment options and bad prognosis. LÄS MER